Approval of the post-approval study protocol.
Device | MAESTRO RECHARGEABLE SYSTEM |
Classification Name | Neuromodulator For Obesity |
Generic Name | Neuromodulator For Obesity |
Applicant | ReShape Lifesciences, Inc. |
Date Received | 2015-02-26 |
Decision Date | 2015-06-02 |
PMA | P130019 |
Supplement | S001 |
Product Code | PIM |
Advisory Committee | Gastroenterology/Urology |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Labeling Change - Pas |
Expedited Review | No |
Combination Product | No |
Applicant Address | ReShape Lifesciences, Inc. 2800 Patton Road saint Paul, MN 55113 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P130019 | | Original Filing |
S019 |
2018-12-17 |
Normal 180 Day Track No User Fee |
S018 |
2018-02-12 |
Real-time Process |
S017 |
2018-02-09 |
Real-time Process |
S016 |
2017-12-28 |
30-day Notice |
S015 |
2017-06-08 |
Normal 180 Day Track No User Fee |
S014 |
2017-04-28 |
Real-time Process |
S013 |
2017-03-02 |
Special (immediate Track) |
S012 |
2016-12-08 |
Special (immediate Track) |
S011 |
2016-09-29 |
Real-time Process |
S010 |
2016-08-26 |
30-day Notice |
S009 |
2016-06-07 |
Normal 180 Day Track No User Fee |
S008 |
2016-05-13 |
30-day Notice |
S007 |
2016-01-20 |
30-day Notice |
S006 |
2015-03-25 |
Real-time Process |
S005 |
2015-03-24 |
Real-time Process |
S004 |
2015-03-23 |
30-day Notice |
S003 |
2015-03-20 |
30-day Notice |
S002 |
2015-02-27 |
Normal 180 Day Track No User Fee |
S001 |
2015-02-26 |
Normal 180 Day Track No User Fee |
NIH GUDID Devices